menu
    • menu

    Company profile for BeyondSpring

    NEW Drugs in Dev: 5
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Headquartered in New York, BeyondSpring Inc. (BeyondSpring) is a global, clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with University of Washington in de novo drug discovery using a ubiquitination platform. BeyondSpring's lead asset, Plinabulin, is in two Phase 3 global clinical trial as a direct anticanc...
    Headquartered in New York, BeyondSpring Inc. (BeyondSpring) is a global, clinical-stage bio-pharmaceutical company developing innovative immuno-oncology cancer therapies with a robust pipeline from internal development and from collaboration with University of Washington in de novo drug discovery using a ubiquitination platform. BeyondSpring's lead asset, Plinabulin, is in two Phase 3 global clinical trial as a direct anticancer agent in the treatment of non-small cell lung cancer (NSCLC) and in the prevention of chemotherapy-induced neutropenia (CIN).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BeyondSpringUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    28 Liberty Street, 39th Floor, New York, NY 10005
    Telephone
    Telephone
    +1 (646) 305-6387
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://beyondspringpharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/beyondspring-pharmaceuticals
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/BeyondSpringInc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Beyondspring To Attend 12Th Immuno-Oncology 360° Conference
    Beyondspring To Attend 12Th Immuno-Oncology 360° Conference

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234417/0/en/BeyondSpring-to-Participate-at-the-12th-Annual-Immuno-Oncology-360-Conference.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    Beyondspring Presents Plinabulin + Docetaxel Data At ESMO Asia
    Beyondspring Presents Plinabulin + Docetaxel Data At ESMO Asia

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204554/0/en/BeyondSpring-Announces-ESMO-Asia-Presentation-on-Plinabulin-Docetaxel-Improving-Survival-in-Large-Phase-3-DUBLIN-3-Asian-Subset-for-EGFR-WT-NSCLC-Compared-to-Docetaxel-Strengthenin.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Beyondspring Reveals Ph3 of Plinabulin+Docetaxel Survival Benefit
    Beyondspring Reveals Ph3 of Plinabulin+Docetaxel Survival Benefit

    11 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/11/3203772/0/en/BeyondSpring-Announces-New-Analyses-of-DUBLIN-3-Phase-3-Study-Showing-Survival-Benefit-of-Plinabulin-Docetaxel-in-Post-Anti-PD-L-1-for-Non-squamous-EGFR-WT-NSCLC-and-a-Reduction-in.html

    GLOBENEWSWIRE
    11 Dec 2025
    Share Share
    BeyondSpring Q2 2025 Result: Clinical Advances and New Leadership
    BeyondSpring Q2 2025 Result: Clinical Advances and New Leadership

    13 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/13/3132541/0/en/BeyondSpring-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update-Accelerates-Momentum-with-Promising-Clinical-Advances-and-Strategic-Leadership-Appointment.html

    GLOBENEWSWIRE
    13 Aug 2025
    Share Share
    BeyondSpring's Plinabulin Drives Dendritic Cell Maturation
    BeyondSpring's Plinabulin Drives Dendritic Cell Maturation

    07 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/07/3110902/0/en/BeyondSpring-Publishes-Human-Clinical-Study-in-Med-Cell-Press-Showing-Plinabulin-Driven-Dendritic-Cell-Maturation-and-Tumor-Response-After-Prior-Checkpoint-Inhibitor-Failure.html

    GLOBENEWSWIRE
    07 Jul 2025
    Share Share
    BeyondSpring Presents Data on Pembrolizumab Combo in NSCLC
    BeyondSpring Presents Data on Pembrolizumab Combo in NSCLC

    03 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/03/3092584/0/en/BeyondSpring-Presents-Efficacy-Safety-Data-from-a-Phase-2-Study-of-Pembrolizumab-plus-Plinabulin-Docetaxel-in-Metastatic-NSCLC-after-Progressing-on-First-Line-Immune-Checkpoint-Inh.html

    GLOBENEWSWIRE
    03 Jun 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search